Ginaton
Ginaton is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Registry-listed formulations
ginaton · mesh:C526713
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
3 source entries across 3 studies. This list may not include all unresolved or historical entries.
- GinatonRegistry intervention
Linked study entry; product equivalence not established
View study and source - Wuling CapsuleRegistry intervention
Linked study entry; product equivalence not established
View study and source - GinatonRegistry intervention
Linked study entry; product equivalence not established
View study and source
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
1
trials recruiting
4
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Study of Wuling Capsule in Treatment Chronic Tinnitus
Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke
The Effect of PAP on ISSHL Comorbided With OSA
Sudden Hearing Loss Multi-center Clinical Trial
Clinical Trials (4)
The Study of Wuling Capsule in Treatment Chronic Tinnitus
Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke
The Effect of PAP on ISSHL Comorbided With OSA
Sudden Hearing Loss Multi-center Clinical Trial
All 4 trials loaded
Drug Details
- Intervention Type
- Drug
- Total Trials
- 4